Rama Krishna Narla

4PUBLICATIONS
63CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 29, 2026
NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

|Nov 03, 2025
Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma.

Zhongying Mo, Lynda Groocock, Scott Wood

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Jul 11, 2021
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.

Rama Krishna Narla, Hardik Modi, Daniel Bauer

Pageof 1

Frequent Collaborators

3 joint publications

Neil Bence

3 joint publications

Andy Christoforou

2 joint publications

Daniel W Pierce

2 joint publications

Jinyi Zhu